Adverse reactions to psychedelic drugs. A review of the literature
- PMID: 6384428
- DOI: 10.1097/00005053-198410000-00001
Adverse reactions to psychedelic drugs. A review of the literature
Abstract
The use of naturally occurring and synthetically derived compounds for their "psychedelic" effects has been a part of human culture for thousands of years. The basic pharmacology of the major synthetic psychedelic compounds (primarily lysergic acid diethylamide [LSD]-25) is described and reference is made to their potentially beneficial psychological effects. Adverse reactions, defined as dysphoric and/or maladaptive/dysfunctional responses to the use of these drugs, sometimes require careful clinical judgment in order to diagnose. These reactions can be effectively classified along a temporal continuum. Acute, short-lived reactions are often fairly benign, whereas chronic, unremitting courses carry a poor prognosis. Delayed, intermittent phenomena ("flashbacks") and LSD-precipitated functional disorders that usually respond to treatment appropriate for the non-psychedelic-precipitated illnesses they resemble, round out this temporal means of classification. The question of organic brain damage as well as permanent changes in personality, attitudes, and creativity in patients and normals who have repeatedly ingested psychedelic drugs is controversial, but tends to point to subtle or nonsignificant changes. Future areas for study of the psychedelics' pharmacological, psychological, and therapeutic effects are suggested.
Similar articles
-
Psychedelic drugs, stress, and the ego. The differential diagnosis of psychosis associated with psychotomimetic drug use.J Nerv Ment Dis. 1973 Apr;156(4):232-41. doi: 10.1097/00005053-197304000-00003. J Nerv Ment Dis. 1973. PMID: 4708883 No abstract available.
-
Lysergic acid diethylamide.Ir Med J. 2001 Jul-Aug;94(7):217. Ir Med J. 2001. PMID: 11693215 Review. No abstract available.
-
Dependence on LSD and other hallucinogenic drugs.JAMA. 1967 Oct 2;202(1):141-4. JAMA. 1967. PMID: 6072003 No abstract available.
-
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.Expert Rev Clin Pharmacol. 2018 Sep;11(9):889-902. doi: 10.1080/17512433.2018.1511424. Epub 2018 Aug 23. Expert Rev Clin Pharmacol. 2018. PMID: 30102078 Review.
-
From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.J Psychoactive Drugs. 2014 Jan-Mar;46(1):3-10. doi: 10.1080/02791072.2014.873684. J Psychoactive Drugs. 2014. PMID: 24830180 Review.
Cited by
-
Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.JAMA Psychiatry. 2024 Sep 4:e242546. doi: 10.1001/jamapsychiatry.2024.2546. Online ahead of print. JAMA Psychiatry. 2024. PMID: 39230883
-
Psychotomimetic compensation versus sensitization.Pharmacol Res Perspect. 2024 Aug;12(4):e1217. doi: 10.1002/prp2.1217. Pharmacol Res Perspect. 2024. PMID: 38923845 Free PMC article. Review.
-
Development of the Japanese version of the Challenging Experience Questionnaire.Neuropsychopharmacol Rep. 2024 Sep;44(3):534-539. doi: 10.1002/npr2.12456. Epub 2024 Jun 18. Neuropsychopharmacol Rep. 2024. PMID: 38889223 Free PMC article.
-
Psychedelics and disorders of consciousness: the current landscape and the path forward.Neurosci Conscious. 2024 Jun 15;2024(1):niae025. doi: 10.1093/nc/niae025. eCollection 2024. Neurosci Conscious. 2024. PMID: 38881630 Free PMC article.
-
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.PCN Rep. 2023 Oct 2;2(4):e146. doi: 10.1002/pcn5.146. eCollection 2023 Dec. PCN Rep. 2023. PMID: 38868739 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources